Guidelines: We'll always need them, we sometimes dislike them, and we have to make them better

Diabetologia

Volumn 53, Issue 11, 2010, Pages 2280-2284

  Kahn, R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical guidelines; Diabetes guidelines; Guidelines

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE;

CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DRUG INFORMATION; EVIDENCE BASED MEDICINE; GLYCEMIC CONTROL; HUMAN; INDIVIDUALIZATION; INTENSIVE CARE; MEDICAL DECISION MAKING; MEDICAL EXPERT; NOTE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION;

EID: 77957669090     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1885-7     Document Type: Note

References (36)

1. DM Eddy 1982 Clinical policies and the quality of clinical practice N Engl J Med 307 343 347 1:STN:280:DyaL383hvF2gug%3D%3D 10.1056/ NEJM198208053070604 7088099
2. DM Eddy 1990 Practice policies-what are they? JAMA 263 877 880 1:STN:280:DyaK3c7ht1Omug%3D%3D 10.1001/jama.263.6.877 2296151 (Pubitemid 20050903)
3. Field MJ, Lohr FN (eds) (1992) Guidelines for clinical practice. From development to use. Institute for Medicine committee on clinical practice guidelines. National Academy Press, Washington
4. LA Bero R Grilli JM Grimshaw, et al. 1998 Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group BMJ 317 465 468 1:STN:280: DyaK1czmvV2htQ%3D%3D 9703533
5. JM Corrigan H Burstin 2007 Measuring quality of performance: where it is headed and who is making the decisions? J Fam Pract 56 4A 7A 17949597
6. RA Kahn EM Gale 2010 Gridlocked guidelines for diabetes Lancet 375 2203 2204 10.1016/S0140-6736(10)60714-3 20609960
7. American Diabetes Association American College of Cardiology Foundation American Heart Association 2009 Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials Diabetes Care 32 187 192 10.2337/dc08-9026
8. American Diabetes Association, European Association for the Study of Diabetes 2009 Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy Diab Care 32 193 203 10.2337/dc08-9025
9. DM Nathan PA Cleary JY Backlund, et al. 2005 Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2643 2653 10.1056/NEJMoa052187 16371630 (Pubitemid 41817713)
10. RR Holman SK Paul MA Bethel DR Matthews HA Neil 2008 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 1577 1589 1:CAS:528:DC%2BD1cXht1Wgt7nK 10.1056/NEJMoa0806470 18784090
11. Action to Control Cardiovascular Risk in Diabetes Study Group 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 2559 10.1056/NEJMoa0802743 (Pubitemid 351831356)
12. Group AC A Patel S MacMahon, et al. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 2572 1:CAS:528:DC%2BD1cXnt1yht7s%3D 10.1056/NEJMicm066227 18539916 (Pubitemid 351214289)
13. W Duckworth C Abraira T Moritz, et al. 2009 Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 129 139 1:CAS:528:DC%2BD1MXnsFWkug%3D%3D 10.1056/NEJMoa0808431 19092145
14. R Lehman HM Krumholz 2009 Tight control of blood glucose in longstanding type 2 diabetes BMJ 338 901 902
15. S Havas 2009 The ACCORD trial and control of blood glucose level in type 2 diabetes mellitus Arch Intern Med 169 150 154 10.1001/archinternmed.2008.518 19171811
16. G Schernthaner AH Barnett DJ Betteridge, et al. 2010 Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis Diabetologia 53 1258 1269 1:CAS:528: DC%2BC3cXmsFyrtrg%3D 10.1007/s00125-010-1702-3 20352408
17. SH Woolf 1993 Practice guidelines: a new reality in medicine. III. Impact on patient care Arch Intern Med 153 2646 2655 1:STN:280:DyaK2c%2FntFGlug%3D%3D 10.1001/archinte.153.23.2646 8250661 (Pubitemid 23353575)
18. TM Shaneyfelt MF Mayo-Smith J Rothwangl 1999 Are guidelines following guidelines? The methodological quality of clinical practice guidelines published in the peer-reviewed medical literature JAMA 281 1900 1905 1:STN:280: DyaK1M3nsleqtA%3D%3D 10.1001/jama.281.20.1900 10349893 (Pubitemid 29242803)
19. NK Choudhry HT Stelfox AS Detsky 2002 Relationship between authors of clinical practice guidelines and the pharmaceutical industry JAMA 287 612 617 10.1001/jama.287.5.612 11829700
20. AS Detsky 2006 Sources of bias for authors of clinical practice guidelines CMAJ 175 1033 1035 17060643
21. FA McAlister S van Diepen RS Padwal, et al. 2007 How evidence based are the recommendations in evidence-based guidelines PLoS Med 4 1325 1332 10.1371/journal.pmed.0040250 (Pubitemid 47358168)
22. AD Sniderman CD Furberg 2009 Why guideline-making needs reform JAMA 301 429 431 1:CAS:528:DC%2BD1MXhtlWgsbc%3D 10.1001/jama.2009.15 19176446
23. RN Shiffman P Shekelle M Overhage, et al. 2003 Standardized reporting of clinical practice guidelines: a proposal from the conference on guideline standardization Ann Intern Med 139 493 498 13679327
24. A Qasseem S Vijan V Snow 2007 Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians Ann Intern Med 147 417 422
25. DM Eddy 1990 Anatomy of a decision JAMA 263 441 443 1:STN:280: DyaK3c%2Fps1egtg%3D%3D 10.1001/jama.263.3.441 2294311 (Pubitemid 20026021)
26. SR Tunis 2007 Reflections on science, judgement, and value on evidence-based decision making: a conversation with David Eddy Health Aff 26 w500 w515 10.1377/hlthaff.26.4.w500
27. I Shrier J-F Boivin RW Platt, et al. 2008 The interpretation of systematic reviews with meta-analyses: an objective or subjective process? BMC Med Inform Dec Making 8 19 10.1186/1472-6947-8-19 (Pubitemid 351792456)
28. CM Boyd J Darer C Boult 2005 Clinical practice guidelines and the quality of care for older patients with multiple comorbid diseases JAMA 294 716 724 1:CAS:528:DC%2BD2MXns1OhsL0%3D 10.1001/jama.294.6.716 16091574 (Pubitemid 41159291)
29. R Kahn RM Robertson R Smith D Eddy 2008 The impact of prevention on reducing the burden of cardiovascular disease Circulation 118 576 585 10.1161/CIRCULATIONAHA.108.190186 18606915
30. PJ O'Connor 2005 Adding value to evidence-based clinical guidelines JAMA 294 741 743 10.1001/jama.294.6.741 16091578 (Pubitemid 41159295)
31. EM Antman DT Anbe PW Armstrong, et al. 2004 ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 110 e82 e292 10.1161/01.CIR.0000134791.68010.FA 15339869 (Pubitemid 39036178)
32. RJ Smith DM Nathan SA Arslanian, et al. 2010 Individualizing therapies in type 2 diabetes mellitus based on patient characteristics; what we know and what we need to know J Clin Endocrinol Metab 95 1566 1574 1:CAS:528: DC%2BC3cXltFSgurY%3D 10.1210/jc.2009-1966 20194712
33. RA Hayward HM Krumholz DM Zulman JW Timble S Vijan 2010 Optimizing statin treatment for primary prevention of coronary artery disease Ann Intern Med 152 69 77 20083825
34. DM Eddy L Schlessinger 2003 Archimedes: a trial validated model of diabetes Diab Care 26 3093 3101 10.2337/diacare.26.11.3093 (Pubitemid 37339504)
35. M Stern K Williams DM Eddy R Kahn 2008 Validation of prediction of diabetes by Archimedes and comparison with other predicting models Diab Care 31 1670 1671 10.2337/dc08-0521
36. American Diabetes Association. Diabetes PHD. Available from www.diabetes.org/living-with-diabetes/complications/diabetes-phd/. Accessed 17 June 2010